IN2012DN03358A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03358A
IN2012DN03358A IN3358DEN2012A IN2012DN03358A IN 2012DN03358 A IN2012DN03358 A IN 2012DN03358A IN 3358DEN2012 A IN3358DEN2012 A IN 3358DEN2012A IN 2012DN03358 A IN2012DN03358 A IN 2012DN03358A
Authority
IN
India
Prior art keywords
relates
compositions
improving
processes
production
Prior art date
Application number
Inventor
Patrick Hossler
Ivan R Correia
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IN2012DN03358A publication Critical patent/IN2012DN03358A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Abstract

The instant invention relates to the field of protein production, and in particular is relates to compositions and processes for improving the production levels of recombinant proteins expressed in host cells.
IN3358DEN2012 2009-11-09 2010-11-09 IN2012DN03358A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25952709P 2009-11-09 2009-11-09
US12/941,347 US8524458B2 (en) 2009-11-09 2010-11-08 Secretory protein biomarkers for high efficiency protein expression
PCT/US2010/055953 WO2011057239A2 (en) 2009-11-09 2010-11-09 Secretory protein biomarkers for high efficiency protein expression

Publications (1)

Publication Number Publication Date
IN2012DN03358A true IN2012DN03358A (en) 2015-10-23

Family

ID=43431809

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3358DEN2012 IN2012DN03358A (en) 2009-11-09 2010-11-09

Country Status (14)

Country Link
US (2) US8524458B2 (en)
EP (1) EP2499254A2 (en)
JP (1) JP2013510324A (en)
KR (1) KR20120115494A (en)
CN (1) CN102666873A (en)
AU (1) AU2010314922A1 (en)
BR (1) BR112012010976A2 (en)
CA (1) CA2778254A1 (en)
IL (1) IL219518A0 (en)
IN (1) IN2012DN03358A (en)
MX (1) MX2012005380A (en)
RU (1) RU2012124114A (en)
WO (1) WO2011057239A2 (en)
ZA (1) ZA201202966B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6507542B2 (en) * 2014-09-22 2019-05-08 東洋紡株式会社 Method of predicting recombinant protein production using biomarkers
EP3255054A1 (en) * 2016-06-06 2017-12-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the purification of biological macromolecular complexes
CN108467890A (en) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 The product of the application and application VAT1 genes of the chaff interferent of VAT1 genes and VAT1 genes
CN109470756B (en) * 2018-10-11 2020-08-25 昆明理工大学 Electrochemical method for determining interaction of 14-3-3 protein and plasma membrane H + -ATPase protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
US5302517A (en) * 1987-06-16 1994-04-12 The Board Of Regents Of The University Of Nebraska Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20050272055A1 (en) * 2000-02-01 2005-12-08 Rina Das Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
MX2008013397A (en) 2006-04-21 2009-03-27 Wyeth Corp Differential expression profiling analysis of cell culture phenotypes and the uses thereof.
US8242057B2 (en) * 2006-06-26 2012-08-14 Cleveland Biolabs, Inc. Methods for identifying modulators of apoptosis
JP2011522265A (en) * 2008-06-04 2011-07-28 プロテオシス アクチエンゲゼルシャフト Protein biomarkers for in vitro testing of developmental and embryonic toxicity of chemicals

Also Published As

Publication number Publication date
WO2011057239A3 (en) 2011-06-30
US20110236906A1 (en) 2011-09-29
MX2012005380A (en) 2012-05-29
KR20120115494A (en) 2012-10-18
BR112012010976A2 (en) 2016-08-16
CA2778254A1 (en) 2011-05-12
US20140004531A1 (en) 2014-01-02
RU2012124114A (en) 2013-12-20
JP2013510324A (en) 2013-03-21
AU2010314922A1 (en) 2012-05-31
CN102666873A (en) 2012-09-12
WO2011057239A2 (en) 2011-05-12
ZA201202966B (en) 2012-12-27
IL219518A0 (en) 2012-06-28
US8524458B2 (en) 2013-09-03
EP2499254A2 (en) 2012-09-19

Similar Documents

Publication Publication Date Title
PH12019500694A1 (en) Factor viii compositions and methods of making and using the same
EP2470559A4 (en) Coagulation factor ix compositions and methods of making and using same
IN2012DN06277A (en)
IN2014CN02100A (en)
MX2013003681A (en) Engineered nucleic acids and methods of use thereof.
IN2012DN03825A (en)
WO2014035475A8 (en) Methods to control protein heterogeneity
WO2011123830A3 (en) Alpha 1-antitrypsin compositions and methods of making and using same
EA201190326A8 (en) GROWTH HORMONE POLYPEPTIDES AND METHODS FOR THEIR PRODUCTION AND APPLICATION
MX351565B (en) COLLAGEN 7 and RELATED METHODS.
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
AU2012257942A8 (en) Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same
MX346700B (en) Method for improving the yield of a polypeptide.
PH12014501912A1 (en) Cx3cr1-binding polypeptides
EA201290565A1 (en) GETTING THE PROTEIN OF HEMAGGLUTININ-NEURAMINIDASE IN MICROWAVES
MX2016008258A (en) Novel eukaryotic cells and methods for recombinantly expressing a product of interest.
WO2012136898A3 (en) Novel cutinases, their production and uses
MX2011012623A (en) Casb7439 constructs.
MY180183A (en) Methods and compositions for preventing norleucine misincorporation into proteins
IN2012DN03358A (en)
WO2013063528A3 (en) Isoprene synthase variants with improved solubility for production of isoprene
NZ709120A (en) Beta-hexosyl-transferases and uses thereof
WO2010108182A3 (en) Production of recombinant proteins in ciliates and uses thereof
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
WO2012129449A3 (en) High level production of recombinant proteins